News

Parkland Corporation Initiates Consent Solicitations Amid Acquisition

Parkland Corporation Initiates Consent Solicitations Amid Acquisition

Parkland Corporation Commences Consent Solicitations

Parkland Corporation (TSX: PKI) has embarked on a significant journey as it initiates consent solicitations aimed at amending the indentures for its outstanding US dollar-denominated and Canadian dollar-denominated notes. This move comes as part of a strategic effort connected to Parkland's agreement with Sunoco LP, which involves the acquisition of Parkland’s common shares.

The Notes Involved in the Consent Solicitations

As part of this undertaking, Parkland is addressing specific series of notes in connection with the consent solicitations. These include the 5.875% Senior Notes due 2027, 6.000% Senior Notes due 2028, 4.375% Senior Notes due 2029, 4.500% Senior Notes due 2029, 4.625% Senior Notes due 2030, and 6.625% Senior Notes due 2032. Each of these series carries distinct characteristics, and the consent solicitations are focused on seeking the necessary approvals to amend the indentures governing these notes.

Understanding the Proposed Amendments

The amendments being proposed by Parkland aim to facilitate the completion of the acquisition. These Proposed Change of Control (COC) Amendments include provisions that eliminate Parkland’s obligations under the indentures relating to making a Change of Control Offer as a result of this transaction. Additionally, it aims to redefine the term “Change of Control” to confirm that Sunoco and its affiliates qualify as owners.

Meeting the Requirements for Consent

To successfully implement the proposed amendments across each series of notes, Parkland requires the consents of holders representing at least a majority of the aggregate outstanding principal amount of each respective series. It’s important to note that obtaining consent for one series does not condition the completion of the solicitation for other series.

Key Deadlines in the Consent Process

Each consent solicitation is time-sensitive. The solicitations are set to expire at 5:00 p.m. Eastern Daylight Time on June 9, 2025. Holders of record for the USD and CAD Notes have designated record dates, marking the cutoff for eligibility to participate in the consent process.

Implications of Change of Control

Under the terms described in the indentures, the acquisition transaction can be classified as a Change of Control. This designation triggers specific rights for noteholders, including the ability to require Parkland to repurchase their notes should a Change of Control Triggering Event occur.

Rating Agencies' Responses

Following the announcement of the acquisition, major rating agencies such as Standard & Poor's, Moody's, and DBRS have all issued reports concerning the impact of this transaction. Encouragingly, none of these reports indicated any downgrades to the current ratings of the notes.

Final Steps and Considerations

In the wake of these significant developments, Parkland is committed to ensuring that all communications regarding the consent solicited are transparent. Stakeholders are encouraged to review the Consent Solicitation Statement, which outlines essential details regarding the terms and conditions associated with the solicitations.

Parkland’s Commitment to Stakeholders

Parkland aims to uphold a high level of engagement with its stakeholders throughout this process, providing clarity and insights into the implications of these solicitation efforts. It is essential for all noteholders to fully understand their options during this critical transition.

Frequently Asked Questions

What are the Consent Solicitations for?

The Consent Solicitations are intended to secure approvals from noteholders to amend the indentures affiliated with Parkland's notes in relation to the Sunoco acquisition.

Who is eligible to participate in the Consent Solicitation?

Only holders of record for the USD and CAD Notes as of specified dates are eligible to deliver consents to the Proposed Amendments.

What amendments are being proposed?

Amendments include eliminating the obligation for Parkland to make a Change of Control Offer and adjusting the definition of Change of Control to include Sunoco as a Qualified Owner.

When does the Consent Solicitation expire?

The consent solicitation is set to expire on June 9, 2025, at 5:00 p.m. Eastern Daylight Time.

How will noteholders be compensated for their consent?

Eligible noteholders who deliver valid and unrevoked consents by the deadline will receive consent fees as specified in the solicitation materials.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 4

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 2

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 0

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 0

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 2

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 3

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 3

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 0

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading

Top 5 Most Recently Viewed Articles

Sable Resources Secures Financing Through Moxico Partnership

Updated Category News Views 148

Sable Resources Secures Financing Through Moxico Partnership Vancouver, British Columbia – Sable Resources Ltd. (“Sable” or the “Company”) (TSXV: SAE | OTCQB: SBLRF) recently announced the successful closing of a non-brokered private placement, raising C$1.75 million in funding. This financing comes from an agreement with Moxico Resources plc, wherein Sable...

Continue Reading
Coherus BioSciences Unveils Robust Q1 2025 Financials

Updated Category News Views 399

Coherus BioSciences Reports Q1 Financial Results Coherus BioSciences, Inc. (Nasdaq: CHRS) has recently released its financial results for the first quarter of 2025. This update also highlights significant developments within the company, especially in the field of oncology. Strategic Focus on Innovative Oncology As part of its strategic transformation towards becoming an...

Continue Reading
Understanding the Rise in Comfort Systems USA's Short Interest

Updated Category News Views 134

Understanding Comfort Systems USA's Short Interest The short interest of Comfort Systems USA (NYSE: FIX) has seen a notable rise, increasing by 40.65% since the last report. This reflects growing concerns or speculation surrounding the company's stock performance. Currently, approximately 536 thousand shares are sold short, which constitutes 2.18% of the total shares...

Continue Reading
Kinetics Noise Control Elevates Logan Herkomer to HVAC Director

Updated Category News Views 129

Kinetics Noise Control Elevates Logan Herkomer to HVAC Director Kinetics Noise Control Inc. (Kinetics), a leader in the noise control products sector, has announced a significant leadership change. Logan Herkomer has been promoted to HVAC Sales Director, a role in which he will oversee the company's national sales strategies for HVAC products. This change is effective...

Continue Reading
Shanghai Electric Showcases Sustainable Innovations at Intersolar

Updated Category News Views 212

Shanghai Electric Showcases Sustainable Innovations at Intersolar Shanghai Electric has made a significant statement at this year's Intersolar Europe, a premier event dedicated to advancing the solar industry. The company's dedication to fostering innovative technologies is evident in its latest offerings in photovoltaic and hydrogen energy, along with advanced energy...

Continue Reading